| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/05/2011 | US7973018 Cell cycle arrest and apoptosis |
| 07/05/2011 | US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids |
| 07/05/2011 | US7972609 Method of treating cancer |
| 07/05/2011 | US7972592 Prevention of type 1 diabetes and other non-polio enterovirus diseases |
| 07/05/2011 | CA2444724C Method for differentiating mesenchymal stem cells into neural cells |
| 07/05/2011 | CA2390081C Modified viral surface proteins which bind to cells of tumor vasculature |
| 07/05/2011 | CA2288540C Defined serumfree medical solution for ophthalmology |
| 07/04/2011 | CA2689386A1 Traditional chinese medicine foundation |
| 06/30/2011 | WO2011079307A2 Methods and compositions for treating neurological disorders |
| 06/30/2011 | WO2011078799A1 Treatment of bone fracture |
| 06/30/2011 | WO2011078677A2 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis |
| 06/30/2011 | WO2011078654A1 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis |
| 06/30/2011 | WO2011078213A1 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof |
| 06/30/2011 | WO2011076007A1 Lactobacillus paracaseistrain lt12 as anti-allergy agent |
| 06/30/2011 | WO2011075848A1 Epsilon-poly-lysine capsules |
| 06/30/2011 | WO2011075777A1 Neuronal stimulation |
| 06/30/2011 | WO2011019366A3 Growth factor extractor |
| 06/30/2011 | WO2011013979A3 Composition containing bee venom as an active ingredient for preventing and treating acne |
| 06/30/2011 | WO2010119088A3 Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity |
| 06/30/2011 | US20110159585 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 06/30/2011 | US20110159131 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels |
| 06/30/2011 | US20110159130 Reduction of endotoxin in polysialic acids |
| 06/30/2011 | US20110159104 Microemulsion |
| 06/30/2011 | US20110159075 Compositions and systems for forming crosslinked biomaterials and methods of preparation and use |
| 06/30/2011 | US20110159071 Isolation and Identification of Glycosaminoglycans |
| 06/30/2011 | US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| 06/30/2011 | US20110159056 Methods and materials for stimulating proliferation of stem cells |
| 06/30/2011 | US20110159053 Preparation of a cell concentrate from a physiological solution |
| 06/30/2011 | US20110159051 Composite for Thermo-Sensitive Cell-Tissue Transplanted Scaffold and Use thereof |
| 06/30/2011 | US20110159043 Allogeneic vaccine and methods to synthesize same |
| 06/30/2011 | US20110159036 MVA expressing modified HIV envelope, GAG, and POL genes |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159017 Trytophan catabolism in cancer treatment and diagnosis |
| 06/30/2011 | US20110158969 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158967 Mesenchymal stem cell and the method of use thereof |
| 06/30/2011 | US20110158966 Stem cells characterized by expression of germline specific genes |
| 06/30/2011 | US20110158965 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells |
| 06/30/2011 | US20110158964 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells |
| 06/30/2011 | US20110158963 Three-dimensional matrices of structured porous monetite for tissue engineering and bone regeneration, and method of the preparation thereof |
| 06/30/2011 | US20110158962 Dental pulp marrow similar cells (dpmsc) and methods of isolating and using |
| 06/30/2011 | US20110158961 Materials and methods relating to cell based therapies |
| 06/30/2011 | US20110158960 Isolation of precursor cells and their use for tissue repair |
| 06/30/2011 | US20110158959 Immunophenotype and immunogenicity of human adipose derived cells |
| 06/30/2011 | US20110158958 Methods for treating ophthalmic disorders, diseases and injuries |
| 06/30/2011 | US20110158957 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| 06/30/2011 | US20110158956 Treating cancer |
| 06/30/2011 | US20110158955 Method for producing cells having characteristic of hematopoietic stem cells/progenitor cells |
| 06/30/2011 | US20110158954 Method for producing gamma delta t cell population |
| 06/30/2011 | US20110158953 Tumor suppression through plexin c1 |
| 06/30/2011 | US20110158952 Compositions and methods for treating human papillomavirus-mediated disease |
| 06/30/2011 | US20110158951 Use of blood group status ii |
| 06/30/2011 | US20110158950 Use of blood group status i |
| 06/30/2011 | US20110158949 Metabolically active micro organisms and methods for their production |
| 06/30/2011 | US20110158948 Treatment Using Herpes Simplex Virus |
| 06/30/2011 | US20110158945 Myxoma virus mutants for cancer treatment |
| 06/30/2011 | US20110158932 Methods And Compositions For The Treatment of Hyperlipidemia |
| 06/30/2011 | CA2785268A1 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof |
| 06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
| 06/29/2011 | EP2338983A1 Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| 06/29/2011 | EP2338982A2 Postpartum cells derived from umbilical cord tissue and methods of making and using the same |
| 06/29/2011 | EP2338981A2 Repair and regeneration of ocular tissue using postpartum umbilical cord-derived cells |
| 06/29/2011 | EP2338980A2 Regeneration and repair of neural tissue using postpartum umbilical cord -derived cells |
| 06/29/2011 | EP2338977A1 Lactobacillus paracasei strain LT12 as immunity regulatory agent |
| 06/29/2011 | EP2338976A1 Lactic acid bacterium having high oxalic acid decomposition ability |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338507A1 Method of treating malignancies through induction of blood immune responses |
| 06/29/2011 | EP2338483A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders using choline |
| 06/29/2011 | EP2338476A1 Suppository for rectal, vaginal or urethral administration containing a probiotic, an antibiotic and an unsaturated non-esterified fatty acid |
| 06/29/2011 | EP2338475A2 Treating canker sores with patches to speed healing and relieve pain |
| 06/29/2011 | EP2338442A1 Particulate cartilage system |
| 06/29/2011 | EP2338441A1 Particulate cartilage system |
| 06/29/2011 | EP2337850A2 Anti-protozoa compounds |
| 06/29/2011 | EP2337617A1 Platelet rich plasma formulations for cardiac treatments |
| 06/29/2011 | EP2337573A1 Whey and thymus function |
| 06/29/2011 | EP2337569A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
| 06/29/2011 | EP2337568A1 Methods and means for soft tissue engineering |
| 06/29/2011 | EP2337556A1 Cosmetic or dermopharmaceutical composition containing pseudoalteromonas ferment extract |
| 06/29/2011 | EP2217253B1 Bifidobacterium for dust mite allergy |
| 06/29/2011 | EP1503788B1 Treatment of alpha-galactosidase a deficiency |
| 06/29/2011 | EP1226234B1 Hair transplantation |
| 06/29/2011 | EP1226233B1 Multipotent adult stem cells and methods for isolation |
| 06/29/2011 | EP1183348B1 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 06/29/2011 | CN201879280U Vehicle-mounted back pillow adopting traditional Chinese medicine for lowering high blood pressure |
| 06/29/2011 | CN1968608B Improved modalities for the treatment of degenerative diseases of the retina |
| 06/29/2011 | CN1806827B Chinese medicinal composition, its preparation process and quality control method |
| 06/29/2011 | CN1427889B Hybrid cells obtainable from antigen presenting cells |
| 06/29/2011 | CN102112623A FVIII muteins for treatment of von willebrand disease |
| 06/29/2011 | CN102112140A Effects of probiotics on humans and animals under environmental or biological changes |
| 06/29/2011 | CN102109273A Method for drying gelatin type traditional Chinese medicine |
| 06/29/2011 | CN102108318A Crocodile grease and preparation method and use thereof |
| 06/29/2011 | CN102106997A Oral Chinese medicine decoction for treating endometriosis |
| 06/29/2011 | CN102106991A Medicament for treating moderate/advanced liver cancer chemoembolization |
| 06/29/2011 | CN102106988A Chinese medicine preparation with effects on expelling wind, dispelling cold and dampness, promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain |
| 06/29/2011 | CN102106987A Preparation method of Chinese medicine for treating cancer |
| 06/29/2011 | CN102106983A Toning liniment and preparation method thereof |
| 06/29/2011 | CN102106982A Chinese medicinal composition for treating chronic hepatitis B in immune clearance phase |
| 06/29/2011 | CN102106979A Medicament for treating hypertension |
| 06/29/2011 | CN102106978A Medicament for treating nephritis |
| 06/29/2011 | CN102106977A Externally-applied sturdy vision eyeshield liquid medicine for preventing and treating oculopathy |